Pure Financial Advisors LLC Acquires 6,919 Shares of Lam Research Corporation $LRCX

Pure Financial Advisors LLC raised its stake in shares of Lam Research Corporation (NASDAQ:LRCX) by 77.3% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 15,874 shares of the semiconductor company’s stock after purchasing an additional 6,919 shares during the quarter. Pure Financial Advisors LLC’s holdings in Lam Research were worth $6,879,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in LRCX. Bayban purchased a new position in shares of Lam Research during the fourth quarter valued at about $26,000. Vermillion Wealth Management Inc. purchased a new stake in Lam Research in the first quarter worth about $26,000. Cedar Mountain Advisors LLC boosted its position in Lam Research by 242.9% during the 1st quarter. Cedar Mountain Advisors LLC now owns 120 shares of the semiconductor company’s stock valued at $26,000 after acquiring an additional 85 shares in the last quarter. Paladin Partners LLC bought a new stake in Lam Research during the 2nd quarter valued at approximately $26,000. Finally, Mcguire Capital Advisors Inc. purchased a new position in shares of Lam Research during the 4th quarter worth approximately $27,000. 84.61% of the stock is currently owned by institutional investors.

Lam Research Trading Down 0.6%

Shares of NASDAQ LRCX opened at $312.88 on Thursday. The firm’s 50 day moving average price is $333.58 and its 200-day moving average price is $288.43. Lam Research Corporation has a 52-week low of $94.11 and a 52-week high of $438.50. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.91 and a current ratio of 2.63. The company has a market cap of $391.51 billion, a PE ratio of 54.32, a P/E/G ratio of 1.25 and a beta of 1.84.

Lam Research (NASDAQ:LRCX) last announced its quarterly earnings results on Wednesday, July 29th. The semiconductor company reported $1.82 earnings per share for the quarter, beating the consensus estimate of $1.69 by $0.13. Lam Research had a net margin of 31.27% and a return on equity of 67.60%. The company had revenue of $6.72 billion during the quarter, compared to the consensus estimate of $6.66 billion. During the same quarter last year, the firm earned $1.33 earnings per share. The firm’s quarterly revenue was up 30.0% compared to the same quarter last year. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. On average, equities research analysts expect that Lam Research Corporation will post 9.32 EPS for the current fiscal year.

Key Headlines Impacting Lam Research

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: AI-focused R&D expansion: Lam Research broke ground on a 120,000-square-foot laboratory in Tualatin, Oregon, as part of a planned investment of more than $3 billion in its global lab network over the next five years. The facility is intended to support collaboration with chipmakers and accelerate equipment innovations for advanced AI semiconductors. Lam Research Oregon lab announcement
• Positive Sentiment: Strong AI demand outlook: CEO Tim Archer said increasingly complex AI models require more computing power, bandwidth and storage, creating demand for semiconductor innovation. The investment reinforces Lam’s positioning as a supplier to the AI infrastructure buildout. Lam Research AI investment video
• Positive Sentiment: Favorable analyst and fundamentals commentary: Zacks highlighted AI-driven growth, recurring services revenue, earnings momentum and Lam’s balance sheet, while Mizuho maintained an “outperform” rating despite trimming its price target to $365 from $370. Lam’s latest reported quarter also showed 30% year-over-year revenue growth and an earnings beat.
• Neutral Sentiment: Investor outreach scheduled: CFO Doug Bettinger will participate in upcoming investor conferences. The events could provide updates on demand, AI exposure and the Oregon investment, but no new financial guidance was announced. Lam Research conference announcement
• Negative Sentiment: Investment and valuation concerns: The multibillion-dollar R&D expansion will raise near-term capital and operating costs, while the stock’s high earnings multiple leaves less room for disappointment. The modest analyst price-target reduction may also have limited enthusiasm.

Insiders Place Their Bets

In related news, Director Abhijit Y. Talwalkar sold 18,282 shares of the stock in a transaction on Monday, July 13th. The stock was sold at an average price of $335.00, for a total transaction of $6,124,470.00. Following the sale, the director directly owned 87,142 shares of the company’s stock, valued at $29,192,570. This trade represents a 17.34% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Neil J. Fernandes sold 7,659 shares of Lam Research stock in a transaction dated Monday, June 1st. The stock was sold at an average price of $309.60, for a total value of $2,371,226.40. Following the completion of the sale, the senior vice president owned 58,470 shares of the company’s stock, valued at $18,102,312. The trade was a 11.58% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 80,441 shares of company stock valued at $27,614,296. Corporate insiders own 0.31% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have recently commented on LRCX. Evercore restated an “outperform” rating and issued a $355.00 target price on shares of Lam Research in a research note on Monday, July 20th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a $320.00 price objective on shares of Lam Research in a report on Thursday, July 30th. Stifel Nicolaus boosted their target price on shares of Lam Research from $325.00 to $425.00 and gave the company a “buy” rating in a report on Friday, July 10th. Citigroup reiterated a “buy” rating and issued a $450.00 price target (up from $315.00) on shares of Lam Research in a research note on Wednesday, June 17th. Finally, UBS Group reissued a “buy” rating and set a $375.00 price target (up from $310.00) on shares of Lam Research in a research report on Tuesday, June 9th. One research analyst has rated the stock with a Strong Buy rating, twenty-six have issued a Buy rating and five have given a Hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $357.31.

Lam Research Profile

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.